Salute e Benessere
Digital Pathology Market to Surpass US$ 3.86 Billion by 2033 as AI-Enabled Diagnostics and Telepathology Redefine Global Healthcare | DataM Intelligence
led by demand for high-resolution slide scanners and imaging platforms.
are experiencing the fastest CAGR, driven by AI-powered diagnostic algorithms, cloud-based platforms, and integration with hospital information systems.
, including managed platforms, consulting, and workflow integration, contributed US$ 240 million in 2024, as hospitals and labs seek end-to-end digital transformation.
reflecting widespread adoption in cancer and chronic disease diagnostics.
valued at US$ 260 million , is expanding steadily, with applications in livestock, companion animals, and zoonotic disease research.
as integrated pathology workflows became central to cancer care and diagnostics.
with high-throughput slide analysis enhancing efficiency and turnaround times.
and are also adopting digital solutions to enhance accuracy and scalability.
The U.S., valued at remains the global leader due to:
Japan's market, valued at is expanding rapidly. Key drivers include:
Philips leads with its , FDA-cleared and widely adopted across hospitals and labs. The company generated
and is focusing on AI and cloud integration.
Roche continues to dominate through its , tightly integrated with oncology diagnostics. Roche's 2024 digital pathology revenues exceeded , supported by strong U.S. and Japan adoption.
A key innovator in Japan , Hamamatsu is expanding its for both clinical and research markets. In 2025, it launched new AI-enhanced scanners tailored for Japanese hospitals.
Both U.S.-based firms are scaling AI-driven software platforms. PathAI secured multi-year contracts with pharma companies in 2025, while Proscia expanded its Concentriq platform into Europe and Asia .
Visiopharm continues to lead in AI image analysis, while 3DHISTECH's whole-slide scanners remain competitive in academic institutions worldwide.
https://www.datamintelligence.com/buy-now-page?report=digital-pathology-market
The is expected to The next decade will be defined by:
The global is at the forefront of healthcare's digital transformation. With revenues projected to climb from the sector represents a critical enabler of precision diagnostics, efficient workflows, and scalable healthcare delivery.
With the U.S. shaping global adoption and Japan setting innovation benchmarks in Asia , digital pathology is poised to become an indispensable pillar of clinical medicine and research.
1. Anatomic Pathology Market Size to Soar to USD 31.1 B by 2030, Fueled by Digital & Molecular Diagnostics.
2. North America Digital Pathology Market Size Poised for Rapid Growth: Projected from USD 449M in 2024 to USD 694M by 2030 on AI & Telepathology Surge.
3. Europe Digital Pathology Market to Quadruple by 2033: AI & Telepathology Drive EUR-Scale Growth.
https://www.datamintelligence.com/reports-subscription
:
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad , Telangana 500039
+1 877-441-4866
: Sai.k@datamintelligence.com
Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/digital-pathology-market-to-surpass-us-3-86-billion-by-2033-as-ai-enabled-diagnostics-and-telepathology-redefine-global-healthcare--datam-intelligence-302567297.html